Hypoglycemic activity of the fungi Cordyceps militaris, Cordyceps sinensis, Tricholoma mongolicum, and Omphalia lapidescens in streptozotocin-induced diabetic rats

被引:186
作者
Zhang, Guoqing
Huang, Yuedong
Bian, Yong
Wong, Jack H.
Ng, T. B.
Wang, Hexiang [1 ]
机构
[1] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China
[2] China Agr Univ, Dept Microbiol, Beijing 100094, Peoples R China
[3] Chinese Univ Hong Kong, Fac Med, Dept Biochem, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1007/s00253-006-0411-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
Crude extracts were prepared from fruiting bodies and mycelia of the medicinal fungus Cordyceps militaris, and a polysaccharide-enriched fraction was obtained after extraction with hot water and ethanol precipitation. Polysaccharide-enriched fractions were similarly prepared from Cordyceps sinensis, Omphalia lapidescens, and Tricholoma mongolicum. The various aforementioned preparations were orally administered into different groups of adult rats 24 h before an intraperitoneal injection of streptozotocin (40 mg/kg body weight), and subsequently daily for another 4 days. The dosage used was 10 mg/kg body weight for polysaccharide-enriched preparations and 100 mg/kg body weight for crude extracts. Control rats received distilled water instead of crude extract or polysaccharide-enriched preparation. It was found in the control rats that plasma glucose level rose from about 90 mg/dl before streptozotocin injection to levels that were maintained at about 300 mg/dl postinjection. All preparations produced hypoglycemic effects. C. militaris polysaccharide-enriched fraction displayed a more prominent effect than that of C. sinensis polysaccharide-enriched fraction which in turn was more potent than that of O. lapidescens and T. mongolicum polysaccharide-enriched fractions. The hypoglycemic effect of C. militaris polysaccharide-enriched fraction was dose-dependent.
引用
收藏
页码:1152 / 1156
页数:5
相关论文
共 31 条
[1]
Cordycepin:: selective growth inhibitor derived from liquid culture of Cordyceps militaris against Clostridium spp. [J].
Ahn, YJ ;
Park, SJ ;
Lee, SG ;
Shin, SC ;
Choi, DH .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (07) :2744-2748
[2]
A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats [J].
Balon, TW ;
Jasman, AP ;
Zhu, JS .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (03) :315-323
[3]
Mouse models in preclinical studies for pachyonychia congenita [J].
Chen, J ;
Roop, DR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2005, 10 (01) :37-46
[4]
Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis [J].
Chiou, WF ;
Chang, PC ;
Chou, CJ ;
Chen, CF .
LIFE SCIENCES, 2000, 66 (14) :1369-1376
[5]
Improvement of insulin resistance and insulin secretion by water extracts of Cordyceps militaris, Phellinus linteus, and Paecilomyces tenuipes in 90% pancreatectomized rats [J].
Choi, SB ;
Park, CH ;
Choi, MK ;
Jun, DW ;
Park, S .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2004, 68 (11) :2257-2264
[6]
Huang Lan-fang, 2004, Zhongguo Zhongyao Zazhi, V29, P762
[7]
Mycelial extract of Cordyceps ophioglossoides prevents neuronal cell death and ameliorates β-amyloid peptide-induced memory deficits in rats [J].
Jin, DQ ;
Park, BC ;
Lee, JS ;
Choi, HD ;
Lee, YS ;
Yang, JH ;
Kim, JA .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (07) :1126-1129
[8]
OCCURRENCE OF GAL-BETA (1-]3) GALNAC-SER/THR IN THE LINKAGE REGION OF POLYGALACTOSAMINE CONTAINING FUNGAL GLYCOPROTEIN FROM CORDYCEPS-OPHIOGLOSSOIDES [J].
KAWAGUCHI, N ;
OHMORI, T ;
TAKESHITA, Y ;
KAWANISHI, G ;
KATAYAMA, S ;
YAMADA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 140 (01) :350-356
[9]
POLYSACCHARIDES IN FUNGI .25. BIOLOGICAL-ACTIVITIES OF 2 GALACTOMANNANS FROM THE INSECT-BODY PORTION OF CHAN-HUA (FUNGUS-CORDYCEPS-CICADAE) [J].
KIHO, T ;
NAGAI, K ;
MIYAMOTO, I ;
WATANABE, T ;
UKAI, S .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1990, 110 (04) :286-288
[10]
Kiho T, 1996, BIOL PHARM BULL, V19, P294, DOI 10.1248/bpb.19.294